Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Net Cash Flow (2016 - 2026)

Angiodynamics' Net Cash Flow history spans 17 years, with the latest figure at -$4.0 million for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 56.57% year-over-year to -$4.0 million; the TTM value through Feb 2026 reached -$8.0 million, up 76.13%, while the annual FY2025 figure was -$20.6 million, 165.67% down from the prior year.
  • Net Cash Flow reached -$4.0 million in Q1 2026 per ANGO's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $17.6 million in Q1 2024 to a low of -$21.2 million in Q3 2024.
  • Average Net Cash Flow over 5 years is $166470.6, with a median of $165000.0 recorded in 2023.
  • The largest YoY upside for Net Cash Flow was 10549.7% in 2024 against a maximum downside of 263.41% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $5.1 million in 2022, then tumbled by 38.88% to $3.1 million in 2023, then plummeted by 119.58% to -$611000.0 in 2024, then soared by 582.49% to $2.9 million in 2025, then tumbled by 235.55% to -$4.0 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Net Cash Flow are -$4.0 million (Q1 2026), $2.9 million (Q4 2025), and -$17.3 million (Q3 2025).